Optimization of biological therapy selection in rheumatoid arthritis: insights into anemia and interleukin-6 pathway

Optimization of biological therapy selection in rheumatoid arthritis: insights into anemia and interleukin-6 pathway

Saved in:

Bibliographic Details
Main Author:	Bora Nam
Format:	Article
Language:	English
Published:	Korean College of Rheumatology 2025-01-01
Series:	Journal of Rheumatic Diseases
Online Access:	http://www.jrd.or.kr/journal/view.html?doi=10.4078/jrd.2024.0133
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of interleukin-6 in the development of atherosclerosis in rheumatoid arthritis
by: Elena Vasilyevna Udachkina, et al.
Published: (2013-10-01)

Blockade of the interleukin-6 signaling pathway in rheumatoid arthritis: Effects on obesity, adipocytokines and glucose metabolism
by: L. V. Kondratyeva, et al.
Published: (2024-01-01)

Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: efficacy and safety during one year of therapy
by: P. A. Shesternya, et al.
Published: (2024-10-01)

The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6)
by: E. L. Nasonov, et al.
Published: (2022-11-01)

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
by: Tomasz Kaczyński, et al.
Published: (2019-09-01)

Management of patients with rheumatoid arthritis in real clinical practice: Switching from interleukin 6 receptor inhibitors to interleukin 6 inhibitor (olokizumab)
by: A. A. Baranov, et al.
Published: (2023-06-01)

Inflammatory factor Interleukin-6 and its correlation with rheumatoid arthritis: A meta-analysis
by: Xiaojuan Hao, et al.
Published: (2024-12-01)

ANEMIA PREVALENCE IN RHEUMATOID ARTHRITIS IN 1979 AND 1999
by: Yu. V. Mouraviev, et al.
Published: (2002-06-01)

B-lymphocyte subpopulations in patients with rheumatoid arthritis and the effect of an interleukin-6 receptor inhibitor on them.
by: E. V. Gerasimova, et al.
Published: (2019-01-01)

Marked Independent Relationship between Circulating Interleukin-6 Concentrations and Endothelial Activation in Rheumatoid Arthritis
by: Patrick H. Dessein, et al.
Published: (2013-01-01)

Dynamics of modified cardiovascular risk factors in patients with rheumatoid arthritis on the background of 5-year therapy with an interleukin 6 receptor inhibitor
by: E. V. Gerasimova, et al.
Published: (2024-03-01)

Obesity in rheumatoid arthritis: impact on response to biologic therapies
by: Zehra Irshad, et al.
Published: (2024-06-01)

IMPACT OF BIOLOGICAL THERAPY ON BONE IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: P. S. Dydykina, et al.
Published: (2014-12-01)

Use of olokizumab, a direct interleukin 6 inhibitor, in the treatment of rheumatoid arthritis: real-world evidence
by: P. A. Shesternya, et al.
Published: (2025-04-01)

Interleukin 6 receptor inhibitors in the treatment of rheumatoid arthritis during the COVID-19 pandemic, Moscow experience
by: A. I. Zagrebneva, et al.
Published: (2022-12-01)

Role of hepcidin in the development of anemia in patients with rheumatoid arthritis
by: Elena Andreyevna Galushko, et al.
Published: (2012-06-01)

BIOLOGICAL THERAPY AND INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS: RELEVANCE AND PROSPECTS
by: B. S. Belov
Published: (2014-06-01)

Therapeutic potential of interleukin 6 inhibitors in difficult-to-treat patients with rheumatoid arthritis (results of a retrospective study)
by: I. V. Pozharov, et al.
Published: (2025-07-01)

Gender Differences in Rheumatoid Arthritis: Interleukin-4 Plays an Important Role
by: Chaojie Yu, et al.
Published: (2020-01-01)

MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF ANEMIA IN RHEUMATOID ARTHRITIS PATIENTS
by: Elena Andreyevna Galushko, et al.
Published: (2012-10-01)

Factors determining long-term success of biologic therapy in rheumatoid arthritis
by: Dmitry Evgenyevich Karateev
Published: (2015-09-01)

Pannus growth regulators as potential targets for biological therapy in rheumatoid arthritis
by: A. S. Mikhaylova, et al.
Published: (2018-04-01)

Personalized medicine: Predictors for the efficiency of biological agent therapy for rheumatoid arthritis
by: M. A. Kotovskaya, et al.
Published: (2017-04-01)

Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia
by: Irina Mikhailovna Marusenko
Published: (2013-12-01)

The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence
by: E. L. Nasonov, et al.
Published: (2019-11-01)

Effect of interleukin 6 blockers on body composition, adipocytokines and insulin-like growth factor 1 in patients with rheumatoid arthritis
by: L. V. Kondratyeva, et al.
Published: (2025-07-01)

ISSUES OF OPTIMIZATION OF METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. I. Gridneva, et al.
Published: (2017-03-01)

Methotrexate induced megaloblastic anemia developed in a with rheumatoid arthritis patient
by: M D Evsikova, et al.
Published: (2004-06-01)

Relationship of anemia with clinicolaboratory measures of inflammation activity in patients with rheumatoid arthritis
by: A E Sizikov, et al.
Published: (2007-10-01)

Experience with the interleukin 6 inhibitor (Olokizumab) in patients with rheumatoid arthritis in real clinical practice: Influence on inflammatory activity and disease outcomes
by: N. A. Lapkina, et al.
Published: (2023-10-01)

Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress
by: Ankit Jain, et al.
Published: (2025-07-01)

Analysis of periodontal status in Polish patients with rheumatoid arthritis treated with biological therapies
by: Joanna Samborska-Mazur, et al.
Published: (2024-11-01)

Impact of Biological Therapies on Quality of Life in Rheumatoid Arthritis: A Narrative Review
by: Mamasaidov A, et al.
Published: (2025-04-01)

Bone Effects of Biologic Drugs in Rheumatoid Arthritis
by: Addolorata Corrado, et al.
Published: (2013-01-01)

BIOBEHAVIORAL THERAPY OF RHEUMATOID ARTHRITIS
by: N. A. Shabanova, et al.
Published: (2013-04-01)

Infliximab in the therapy of rheumatoid arthritis
by: G. V. Lukina, et al.
Published: (2016-05-01)

Adjunctive Therapies in Rheumatoid Arthritis
by: Tonatiuh González Heredia, et al.
Published: (2024-11-01)

AN ECONOMIC PRICE ANALYSIS OF CONVENTIONAL REMISSION THERAPY VS BIOLOGICAL THERAPY FOR RHEUMATOID ARTHRITIS TREATMENT
by: Mihaela-Simona SUBTIRELU, et al.
Published: (2019-05-01)

Serum Interleukin-17 and Its Association with Inflammation and Bone Remodeling in Rheumatoid Arthritis and Hand Osteoarthritis: Insights from Musculoskeletal Ultrasound
by: Amany M. Ebaid, et al.
Published: (2025-05-01)

Gene Expression and Polymorphism of Interleukin-4 in a Sample of Iraqi Rheumatoid Arthritis Patients
by: Baghdad Science Journal
Published: (2018-06-01)